Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medistim | Oslo | Healthcare | Healthcare Equipment & Supplies | NOK 3.31B | 32x | NOK 181.50 | 4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.9% Downside | Upgrade to Pro+ | ||
Nordhealth As | Oslo | Healthcare | Healthcare Equipment & Supplies | NOK 2.98B | -32.7x | NOK 40 | 6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23% Upside | Upgrade to Pro+ | ||
Photocure | Oslo | Healthcare | Pharmaceuticals | NOK 1.34B | 95.8x | 0.49 | NOK 49.80 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vistin Pharma ASA | Oslo | Healthcare | Pharmaceuticals | NOK 1.11B | 17.6x | 0.45 | NOK 24.50 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arcticzymes Tech | Oslo | Healthcare | Biotechnology & Medical Research | NOK 964.23M | 125.9x | -2.05 | NOK 18.90 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.5% Upside | Upgrade to Pro+ | |
Omda AS | Oslo | Healthcare | Healthcare Equipment & Supplies | NOK 737.59M | -13.1x | 0.08 | NOK 38 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.4% Upside | Upgrade to Pro+ | |
Gentian Diagnostics | Oslo | Healthcare | Healthcare Equipment & Supplies | NOK 734.10M | 16.2x | 0.03 | NOK 47.60 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.8% Upside | Upgrade to Pro+ | |
Nykode Therapeutics | Oslo | Healthcare | Biotechnology & Medical Research | NOK 702.07M | -1.9x | NOK 2.18 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Thor Medical | Oslo | Healthcare | Biotechnology & Medical Research | NOK 644.54M | -36.8x | NOK 2.05 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
INIFY Laboratories | Oslo | Healthcare | Healthcare Equipment & Supplies | NOK 535.62M | NOK 6.95 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ContextVision AB | Oslo | Healthcare | Healthcare Equipment & Supplies | NOK 464.21M | 20x | -0.77 | NOK 6 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.7% Upside | Upgrade to Pro+ | |
Navamedic | Oslo | Healthcare | Pharmaceuticals | NOK 370.92M | 13.6x | NOK 21 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Lytix Biopharma AS | Oslo | Healthcare | Biotechnology & Medical Research | NOK 324.93M | -3.2x | -0.17 | NOK 4.95 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Exact Therapeutics AS | Oslo | Healthcare | Biotechnology & Medical Research | NOK 242.93M | -3.5x | 0.11 | NOK 3.84 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lifecare | Oslo | Healthcare | Biotechnology & Medical Research | NOK 173.58M | -2.1x | 0.05 | NOK 11 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncoinvent | Oslo | Healthcare | Pharmaceuticals | NOK 156.39M | NOK 1.70 | 6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Arctic Bioscience AS | Oslo | Healthcare | Pharmaceuticals | NOK 103M | -7.2x | 0.12 | NOK 4.10 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Observe Medical | Oslo | Healthcare | Healthcare Equipment & Supplies | NOK 77.22M | -0.9x | -0.03 | NOK 4.46 | 11.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zelluna | Oslo | Healthcare | Biotechnology & Medical Research | NOK 73.63M | -0.4x | 0.06 | NOK 2.19 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SoftOx Solutions | Oslo | Healthcare | Biotechnology & Medical Research | NOK 69.85M | NOK 0.04 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Bergenbio | Oslo | Healthcare | Biotechnology & Medical Research | NOK 62.54M | -0.4x | -0.01 | NOK 1.63 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18% Upside | Upgrade to Pro+ | |
Circio Holding | Oslo | Healthcare | Biotechnology & Medical Research | NOK 48.99M | 0.5x | 0.05 | NOK 0.60 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PCI Biotech | Oslo | Healthcare | Biotechnology & Medical Research | NOK 48.90M | -3x | -0.17 | NOK 1.31 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Codelab Capital AS | Oslo | Healthcare | Healthcare Equipment & Supplies | NOK 25.22M | NOK 0.07 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |